Changes in chromatin structure and methylation of the human interleukin-1beta gene during monopoiesis

Immunology. 2010 Jul;130(3):410-7. doi: 10.1111/j.1365-2567.2009.03243.x. Epub 2010 Feb 5.

Abstract

Interleukin-1beta (IL-1beta) induces the expression of a variety of proteins responsible for acute inflammation and chronic inflammatory diseases. However, the molecular regulation of IL-1beta expression in myeloid differentiation has not been elucidated. In this study the chromatin structure of the IL-1beta promoter and the impact of methylation on IL-1beta expression in monocytic development were examined. The results revealed that the IL-1beta promoter was inaccessible in undifferentiated promyeloid HL-60 cells but highly accessible in differentiated monocytic cells which additionally acquired the ability to produce IL-1beta. Accessibilities of differentiated cells were comparable to those of primary monocytes. Lipopolysaccharide (LPS) stimulation did not affect promoter accessibility in promyeloid and monocytic HL-60 cells, demonstrating that the chromatin remodelling of the IL-1beta promoter depends on differentiation and not on the transcriptional status of the cell. Demethylation via 5-aza-2'-deoxycytodine led to the induction of IL-1beta expression in undifferentiated and differentiated cells, which could be increased after LPS stimulation. Our data indicate that the IL-1beta promoter is reorganized into an open poised conformation during monopoiesis being a privilege of mature monocytes but not of the entire myeloid lineage. As a second mechanism, IL-1beta expression is regulated by methylation acting independently of the developmental stage of myeloid cells.

MeSH terms

  • Azacitidine / analogs & derivatives
  • Azacitidine / pharmacology
  • Calcitriol / pharmacology
  • Cell Differentiation / drug effects
  • Cell Differentiation / physiology
  • Cell Line, Tumor
  • Chromatin Assembly and Disassembly / physiology*
  • Cytokines / metabolism
  • DNA / metabolism
  • DNA Methylation / drug effects
  • DNA Methylation / physiology*
  • DNA Modification Methylases / antagonists & inhibitors
  • Decitabine
  • Enzyme Inhibitors / pharmacology
  • Gene Expression / drug effects
  • Gene Expression / genetics
  • Gene Expression Regulation, Leukemic / physiology*
  • HL-60 Cells
  • Histone Deacetylase Inhibitors / pharmacology
  • Humans
  • Hydroxamic Acids / pharmacology
  • Interleukin-1beta / genetics*
  • Interleukin-1beta / metabolism
  • Lipopolysaccharide Receptors / metabolism
  • Lipopolysaccharides / pharmacology
  • Micrococcal Nuclease / metabolism
  • Monocytes / cytology*
  • Monocytes / drug effects
  • Monocytes / metabolism
  • Myelopoiesis / drug effects
  • Myelopoiesis / physiology*
  • Promoter Regions, Genetic / genetics

Substances

  • Cytokines
  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Interleukin-1beta
  • Lipopolysaccharide Receptors
  • Lipopolysaccharides
  • trichostatin A
  • Decitabine
  • DNA
  • DNA Modification Methylases
  • Micrococcal Nuclease
  • Calcitriol
  • Azacitidine